Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization

MAPK/ERK通路 肾透明细胞癌 肾细胞癌 基因 免疫系统 免疫疗法 表观遗传学 生物 肿瘤科 医学 癌症研究 激酶 遗传学 免疫学
作者
Xinyi Zheng,Yiqiu Wang,Xiaoyan Qiu
出处
期刊:European Journal of Pharmacology [Elsevier BV]
卷期号:980: 176840-176840 被引量:1
标识
DOI:10.1016/j.ejphar.2024.176840
摘要

Mitogen-activated protein kinase (MAPK) signalling is vitally important in tumour development and progression. This study is the first to comprehensively analyse the role of MAPK-family genes in the progression, prognosis, immune-cell infiltration, methylation, and potential therapeutic value drug candidates in ccRCC. We identified a novel prognostic panel of six MAPK-signature genes (MAP3K12, MAP3K1, MAP3K5, MAPK1, MAPK8, MAPK9), and introduced a robust MAPK-signature risk model for predicting ccRCC prognosis. Model construction, evaluation, and external validation using datasets from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database demonstrated its stability, as well as high sensitivity and specificity. Enrichment analysis suggested the participation of immune-mediated mechanism in MAPK dysregulation in ccRCC. Immune-infiltration analysis confirmed the relationship and revealed that the MAPK-signature risk model might stratify immunotherapy response in ccRCC, which was verified in drug sensitivity analysis and validated in external ccRCC immunotherapy dataset (GSE67501). Potential therapeutic drug predictions for key MAPKs using DSigDB, Network Analyst, CTD, and DGIdb were subsequently verified by molecular docking with AutoDock Vina and PyMol. Mendelian randomization further demonstrated the possibilities of the MAPK-signature genes as targets for therapeutic drugs in ccRCC. Methylation analysis using UALCAN and MethSurv revealed the participation of epigenetic modifications in dysregulation and survival difference of MAPK pathway in ccRCC. Among the key MAPKs, MAP3K12 exhibited the highest significance, indicating its independent prognostic value as single gene in ccRCC. Knockout and overexpression validation experiments in vitro and in vivo found that MAP3K12 acted as a promoter of tumour progression in RCC, suggesting a pivotal role for MAP3K12 in the proliferation, migration, and invasion of RCC cells. Our findings proposed the potential of MAPK-signature genes as biomarkers for prognosis and therapy response, as well as targets for therapeutic drugs in ccRCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈昊完成签到,获得积分10
5秒前
6秒前
tian发布了新的文献求助10
8秒前
11秒前
11秒前
龙舞星完成签到,获得积分10
12秒前
13秒前
王涉发布了新的文献求助10
15秒前
普鲁卡因发布了新的文献求助10
16秒前
量子星尘发布了新的文献求助10
18秒前
柚子完成签到,获得积分10
22秒前
23秒前
马儿饿了要吃草完成签到,获得积分10
23秒前
25秒前
sudor123456完成签到,获得积分10
30秒前
NXK发布了新的文献求助10
30秒前
打打应助普鲁卡因采纳,获得10
33秒前
35秒前
lii完成签到,获得积分10
35秒前
jiaolulu发布了新的文献求助10
41秒前
个性惜蕊完成签到,获得积分10
41秒前
44秒前
轩辕书白完成签到,获得积分10
45秒前
qinzhikai完成签到,获得积分10
49秒前
天真的冬瓜完成签到,获得积分10
50秒前
小溜溜完成签到 ,获得积分10
51秒前
普鲁卡因发布了新的文献求助10
52秒前
tian发布了新的文献求助10
53秒前
桃花源的瓶起子完成签到 ,获得积分10
57秒前
平凡世界完成签到 ,获得积分10
58秒前
YYLLTX完成签到,获得积分10
59秒前
畅快山兰完成签到 ,获得积分10
59秒前
gaoxiaogao完成签到,获得积分10
59秒前
舒适怀寒完成签到 ,获得积分10
59秒前
shenglll完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
普鲁卡因发布了新的文献求助10
1分钟前
Liang完成签到,获得积分10
1分钟前
爱思考的小笨笨完成签到,获得积分10
1分钟前
123456完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022